Detalles de la búsqueda
1.
Catecholic amides as potential selective phosphodiesterase 4D inhibitors: Design, synthesis, pharmacological evaluation and structure-activity relationships.
Bioorg Med Chem
; 23(22): 7332-9, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26526739
2.
Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products.
World J Diabetes
; 12(8): 1146-1163, 2021 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34512884
3.
Design, synthesis and biological evaluation of substituted aminopyridazin-3(2H)-ones as G0/G1-phase arresting agents with apoptosis-inducing activities.
Eur J Med Chem
; 141: 440-445, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29040954
4.
Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like Effects at Non-emetic Doses.
ACS Chem Neurosci
; 8(1): 135-146, 2017 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-27690383
5.
Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: Design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings.
Eur J Med Chem
; 124: 372-379, 2016 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-27597413
6.
Synthesis and anticancer activities of 3-arylflavone-8-acetic acid derivatives.
Eur J Med Chem
; 90: 251-7, 2015 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-25461325
7.
Correction to Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like Effects at Non-emetic Doses.
ACS Chem Neurosci
; 9(7): 1868, 2018 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29897231
Resultados
1 -
7
de 7
1
Próxima >
>>